Gallstone recurrence after successful dissolution therapy

Digestive Diseases and Sciences

Volumn 41, Issue 2, 1996, Pages 235-241

  Tudyka, Jürgen ^a   Wechsler, Johannes Georg ^b   Kratzer, Wolfgang ^b   Maier, Christine ^b   Mason, Richard ^b   Kuhn, Klaus ^b   Adler, Guido ^b  

^a Urologische Abteilung   (Germany)

^b NONE

Author keywords

Aspirin; Bile acids; Biliary lipids; Extracorporeal shock wave lithotripsy; Gallstone recurrence; Prevention of recurrent gallstones; Ursodeoxycholic acid

Indexed keywords

ACETYLSALICYLIC ACID; LIPID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE; CHOLELITHIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FEMALE; HUMAN; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CHENODEOXYCHOLIC ACID; CHOLAGOGUES AND CHOLERETICS; CHOLELITHIASIS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; URSODEOXYCHOLIC ACID;

EID: 0029920711     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02093810     Document Type: Article

References (26)

1. Allen G, Borody TJ, Bugliosi TF, May GR, LaRusso NF, Thistle JL: Rapid dissolution of gallstones by methyl tert-butyl ether. N Engl J Med 31:217-220, 1985
2. Thistle JL, May GR, Bender CE, et al: Dissolution of cholesterol gallbladder stones using methyl tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med 320:633-639, 1989
3. Sackmann M, Ippisch E, Sauerbruch T, Holl J, Paumgartner G: Early gallstone recurrence after successful shock wave therapy. Hepatology 8:1221, 1988
4. Villanova N, Bazzoli F, Taroni F, et al: Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 97:726-731, 1989
5. Lee SP, Carey MC, LaMont JT: Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 211:1429-1430, 1981
6. Perez-Aquilar F, Breto M, Alfonso V, Martinez-Silvestre M, Berenguer J: Gallstone recurrence following cessation of dissolving treatment and during prophylactic administration of either low-dose chenodeoxycholic acid (CDCA) or medium-dose ursodeoxycholic acid (UDCA). J Hepatol 1:305, 1986
7. Sylvestrowicz TA, Shaffer EA: Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones. Gastroenterology 95:740-748, 1988
8. Einarsson K, Nilsell K, Leijd B, Angelin B: Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 313:277-282, 1985
9. Maclure KM, Hayes KC, Golditz GA, Stampfer MJ, Speizer FE, Willett WC: Weight, diet, and the risk of symptomatic gallstones in the middle-aged woman. N Engl J Med 321:563-569, 1989
10. Sauerbruch T, Delius M, Paumgartner G, et al: Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 314:818-822, 1986
11. Dodds WJ, Groh WJ, Darweesh RMA, et al: Sonographic measurement of gallbladder volume. Am J Radiol 145:1009-1010, 1985
12. Janowitz P, Swobodnik W, Wechsler JG, et al: A comparison of gallbladder bile and endoscopically obtained duodenal bile. Gut 31:1407-1410, 1990
13. Swobodnik W, Klüppelberg U, Wechsler JG, et al: Rapid and accurate reversed-phase high performance liquid chromatographic determination of conjugated bile acids in human bile for routine clinical application. Therapeutic control during gallstone dissolution therapy. J Chromatogr 339:263-271, 1985
14. Carey MC: Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945-955, 1978
15. Kuroki S, Cohen IB, Carey MC, et al: Rapid computation with the personal computer of the percent cholesterol saturation of bile samples. J Lipid Res 27:442-446, 1986
16. Janowitz P, Kuhn K, Kratzer W, et al: Biliary lipids, cholesterol saturation index, nucleation time and the incidence of symptomatic infections after eswl in contaminated and noncontaminated gallbladder. J Stone Dis 5:148-154, 1993
17. Holan KR, Holzbach RT, Herrmann RE, et al: Nucleation time: A key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 77:611-617, 1979
18. Swobodnik W, Wenk H, Janowitz P, et al: Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls. Scand J Gastroenterol 26:771-778, 1991
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Spengler U, Sackmann M, Sauerbruch T, Holl J, Paumgartner G: Gallbladder motility before and after extracorporeal shock wave lithotripsy. Gastroenterology 96:860-863, 1989
21. O'Donnell LD, Heaton KW: Recurrence and re-recurrence of gallstones after medical dissolution: A long-term follow up. Gut 29:655-658, 1988
22. Dowling RH, Gleeson DC, Hood KA, Ruppin DC, British-Belgian Gallstone Study Group: Gallstone recurrence and postdissolution management. In Bile Acids and the Liver. G Paumgartner, A Stiehl, W Gerok (eds). Lancaster, England, MTP Press, 1987, pp 355-367
23. Lanzini A: Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 3:241-246, 1986
24. Tint GS, Salen G, Chazen D: Symptomatic gallstones are likely to reoccur after dissolution with ursodeoxycholic acid (UDCA), but this may be prevented by low-dose UDCA. Gastroenterology 92(A):1787, 1987
25. Wechsler JG, Swobodnik W, Wenzel K, et al: Ballaststoffe vom Typ Weizenkleie senken die Lithogenität der Galle. Dtsch Med Wochenschr 109:1284-1288, 1984
26. Wechsler JG, Wenzel H, Swobodnik W, Splitt S, Janowitz P, Ditschuneit H: Diätetische Beeinflussung der biliären Lipide. Leber Magen Darm 1:46-54, 1988